ImetelChat

I thinks its worthwhile to remember that only twenty patients were analyzed in the high does arm after three months of therapy--that is, they each at the time of analysis had received four doses of Imetelstat. 20 patients, four doses, the last of which might have only been in for a short week or so. In these 20 patients who received four doses of med, encouraging positive trends are being noted. Seems a little premature to call the game on account of rain. bp

Makes sense, bp. The data were encouraging enough for JnJ to 1) keep the trial going and 2) move over the 4.7 to the 9.4 arm. Even after this short period of time. All this negativity is really strange. The positive is that we have a buying opportunity. Absolutely no reason for me to sell. I can imagine that for some this takes too long. I still have dry powder so I can wait. Long = Long.